Advertisement
Screener

VERACYTE, INC. (VCYT) Payments to Acquire Held-to-maturity Securities

3.4 / 5 stars · 67/98 Roast Me

VERACYTE, INC. Payments to Acquire Held-to-maturity Securities

VERACYTE, INC. (VCYT) reported Payments to Acquire Held-to-maturity Securities of $185.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireHeldToMaturitySecurities · last filed 2026-07-31

  • VERACYTE, INC. payments to acquire held-to-maturity securities for the quarter ending 2026-06-30 was $60.00M, a 20.00% increase year-over-year.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for the quarter ending 2026-03-31 was $125.00M, a 150.00% increase year-over-year.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for the quarter ending 2025-12-31 was $50.00M, a 0.00% change year-over-year.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for the quarter ending 2025-09-30 was $0.00.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for fiscal 2025 was $150.00M, a 200.00% increase from fiscal 2024.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for fiscal 2024 was $50.00M, a 153.81% increase from fiscal 2023.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for fiscal 2023 was $19.70M, a 41.23% decline from fiscal 2022.
  • VERACYTE, INC. payments to acquire held-to-maturity securities for fiscal 2022 was $33.52M.
Period endPayments to Acquire Held-to-maturity Securities 3 monthPayments to Acquire Held-to-maturity Securities 6 monthPayments to Acquire Held-to-maturity Securities 9 monthPayments to Acquire Held-to-maturity Securities 12 month
2026-06-30$60.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$185.00M
10-Q · filed 2026-07-31
$235.00M
derived: sum of 3 quarters · filed 2026-07-31
$235.00M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$125.00M
10-Q · filed 2026-05-06
$175.00M
derived: sum of 2 quarters · filed 2026-05-06
$175.00M
derived: sum of 3 quarters · filed 2026-05-06
$225.00M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$50.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$50.00M
derived: sum of 2 quarters · filed 2026-02-26
$100.00M
derived: sum of 3 quarters · filed 2026-07-31
$150.00M
10-K · filed 2026-02-26
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$50.00M
derived: sum of 2 quarters · filed 2026-07-31
$100.00M
10-Q · filed 2025-11-05
$150.00M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$50.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$100.00M
10-Q · filed 2026-07-31
$150.00M
derived: sum of 3 quarters · filed 2026-07-31
$150.00M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$50.00M
10-Q · filed 2026-05-06
$100.00M
derived: sum of 2 quarters · filed 2026-05-06
$100.00M
derived: sum of 3 quarters · filed 2026-05-06
$100.00M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$50.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$50.00M
derived: sum of 2 quarters · filed 2026-02-26
$50.00M
derived: sum of 3 quarters · filed 2026-02-26
$50.00M
10-K · filed 2026-02-26
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$0.00
derived: sum of 2 quarters · filed 2025-11-05
$0.00
10-Q · filed 2025-11-05
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$0.00
10-Q · filed 2025-05-08
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$19.70M
10-K · filed 2026-02-26
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$19.70M
10-Q · filed 2024-11-07
$44.25M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$19.70M
10-Q · filed 2024-08-07
$44.25M
derived: sum of 3 quarters · filed 2025-02-28
$44.25M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$19.70M
10-Q · filed 2024-05-08
$44.25M
derived: sum of 2 quarters · filed 2025-02-28
$44.25M
derived: sum of 3 quarters · filed 2025-02-28
$53.22M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$24.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$24.55M
derived: sum of 2 quarters · filed 2025-02-28
$33.52M
derived: sum of 3 quarters · filed 2025-02-28
$33.52M
10-K · filed 2025-02-28
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$8.97M
derived: sum of 2 quarters · filed 2023-11-08
$8.97M
10-Q · filed 2023-11-08
$8.97M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$8.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$8.97M
10-Q · filed 2023-08-09
$8.97M
derived: sum of 3 quarters · filed 2024-02-29
$8.97M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$0.00
10-Q · filed 2023-05-05
$0.00
derived: sum of 2 quarters · filed 2024-02-29
$0.00
derived: sum of 3 quarters · filed 2024-02-29
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$0.00
derived: sum of 2 quarters · filed 2024-02-29
$0.00
10-K · filed 2024-02-29
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$0.00
10-Q · filed 2022-11-03
2021-06-30$0.00
10-Q · filed 2022-08-03
2020-12-31$0.00
10-K · filed 2023-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B